BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 27460899)

  • 1. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
    Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
    Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
    Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
    J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL; Williams JH; Davie MW; Marshall MJ
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs.
    Cabahug-Zuckerman P; Frikha-Benayed D; Majeska RJ; Tuthill A; Yakar S; Judex S; Schaffler MB
    J Bone Miner Res; 2016 Jul; 31(7):1356-65. PubMed ID: 26852281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation.
    Fu Q; Bustamante-Gomez NC; Reyes-Pardo H; Gubrij I; Escalona-Vargas D; Thostenson JD; Palmieri M; Goellner JJ; Nookaew I; Barnes CL; Stambough JB; Ambrogini E; O'Brien CA
    JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37581932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
    Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
    J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
    Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.
    Xiong J; Piemontese M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
    Bone; 2014 Sep; 66():146-54. PubMed ID: 24933342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
    Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
    Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.
    Koide M; Kobayashi Y; Ninomiya T; Nakamura M; Yasuda H; Arai Y; Okahashi N; Yoshinari N; Takahashi N; Udagawa N
    Endocrinology; 2013 Feb; 154(2):773-82. PubMed ID: 23291450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.